A groundbreaking new story from the team at Project Veritas reveals that Pfizer is secretly working on “mutating” SARS-CoV-2, the virus that caused COVID-19. According to Jordon Trishton Walker – Pfizer’s Director of Research and Development, Strategic Operations and mRNA Scientific Planning – the pharmaceutical behemoth is actively trying to mutate the virus to produce new strains that don’t currently exist in nature.
According to Walker, Pfizer hopes to use these new viral strains to create new “vaccines” which he says will be a “cash cow” for Pfizer, its executives, and its investors. Additionally, he is seemingly not concerned about pushback from regulators, citing the “revolving door” between state officials and industry corporations.
Still, Walker understands that gain-of-function research is not something that Pfizer should be doing with SARS-CoV-2 and so (as we’ve seen time and again) he refers to the research as “directed evolution.” It’s important to understand the distinction.
Directed evolution is the laboratory process by which biological entities with desired traits are created through iterative rounds of genetic diversification and library screening or selection. Gain-of-function refers to any selection process involving an alteration of genotypes and their resulting phenotypes.
And so, while it’s true that not all directed evolution results in gain-of-function, the use of directed evolution to create new strains of a coronavirus absolutely is. In fact, Walker describes Pfizer’s experiments as “selected structure mutations to try to see if we can make them more potent.”
He goes on to acknowledge that an outbreak of one of these mutated viruses would be “a risk” and that “no one wants to be having a pharma company mutating [expletive] viruses.” What’s especially telling is how Walker refers to this as a risk of “more outbreaks,” implying that it wouldn’t be the first time a mutated virus escaped into the global population.
That inference is confirmed later in the interview, when he specifically references the theory that SARS-CoV-2 originated from a lab in Wuhan, China (an increasingly viable theory that is a subject of our lawsuit against Legacy Media). Here’s another direct quote from Walker, who had just finished explaining how Pfizer scientists are able to mutate the virus:
“…you have to be, like, very controlled to make sure that this virus that you mutate doesn’t create something like, you know, just goes everywhere. Which, I suspect, is the way that the virus started in Wuhan, to be honest. Like, it makes no sense that this virus popped out of nowhere.” (emphasis added)
Nevertheless, Walker seemed to have little (if any) concern about intervention or consequences from government agencies or regulatory bodies. With a smile on his face, the high-ranking Pfizer employee acknowledges that his company “is a revolving door for all government officials.”
The influence of major companies is not limited to the FDA, nor is it limited to leadership.
After law school, Ajit Pai worked for the Antitrust Division of the DoJ as an Honors Program trial attorney on the Telecommunications Task Force. He eventually left that job to become Associate General Counsel at Verizon, where he handled regulatory issues. He eventually moved on the the FCC, where he spent 5 years as its chairman. He now works for a private equity firm that invests in internet and other tech companies.
From 2017 until 2021, Sonny Perdue served as the Secretary of Agriculture. Before his appointment, Perdue was a veterinarian, fertilizer salesman, and Governor of Georgia. Having developed many contacts in the agricultural profession, Perdue has received hundreds of thousands of dollars in campaign donations from the industry. Upon his appointment, he introduced a roster of severely under qualified candidates to influential positions within the government’s agricultural oversight department. In 2021, it was revealed that Perdue had engaged in highly suspicious financial activities with Archer-Daniels-Midland, an agricultural business he would regulate for the next 5 years.
If these conflicts weren’t enough, consider this: 75% of the FDA’s drug review budget comes from the biopharmaceutical industry. This has led to hundreds of risky drugs being rushed to market without adequate proof of safety. Even independent advisors often receive payments from the industry after drugs are approved.
Walker understands this relationship, saying that “…all the government officials who, you know, review our drugs, eventually, come work for pharma companies.”
But it’s not just government officials who are corrupted by the deep pockets of Big Pharma.
When a new therapy is up for FDA approval, advisory committees are formed to review the new drug and vote on whether or not it should be approved. The FDA always follows these recommendations. But a look into the finances of these committee members paints a more sinister picture. Physicians who sit on these advisory boards nearly always end up taking money from the companies relying on their votes. These bribes are not well-masked, showing up as consulting fees, travel compensation, or research grants.
According to sciencemag.org, “An analysis of pharma payments to 107 physicians who advised FDA on 28 drugs approved from 2008 to 2014 found that a majority later got money for travel or consulting or received research subsidies from the makers of the drugs on which they voted or from competing firms.”
Doctors expect gifts from Big Pharma the way waiters expect tips from their guests. It’s not required, but it’s expected. This works out great for physicians and pharmaceutical companies, but not for Americans who are trusting these institutions to put safety and efficacy above all else when introducing a new drug to the market.
Which is exactly what Walker said:
“It’s pretty good for the industry to be honest. It’s bad for everyone else in America. Because if the regulators, who review our drugs, you know that once they stop being a regulator, they want to go work for the company, they are not going to be as harsh on the company where they’re getting their job.”
This is not a conspiracy theory.
Pharmaceutical companies like Pfizer know that they can obtain favorable outcomes from regulators by offering them jobs or other compensation once they’ve left their government posts. This is not a wild, anti-vax fiction designed to undermine the government’s regulatory institutions. This is how the system works, as told by one of its biggest benefactors.
Dr. Robert Malone chimed in on the report:
“…would it be feasible for Pfizer to circumvent international or national law? I think that is undeniable.[Walker] has clearly indicated that Pfizer believes that it has successfully captured the regulatory apparatus of the United States Government.”
In a follow-up call with Project Veritas, Dr. Malone, and others, a question was posed: If Pfizer is able to mutate the virus, and if it has developed vaccines for that mutation, what is to stop the company from releasing that virus to ensure profit instead of loss on the project?
The answer can only be speculative, but if the company’s history is any indication, there may be no depth to which Pfizer will not sink to generate profits.